Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2016 Publisher: Biotest Pharma GmbH, Landsteinerstrasse 5, 63303 Dreieich, Germany, Phone: +49 6103 801-0, Fax: +49 6103 801-150, mail@biotest.de
Haemonine 500.
Haemonine 1000.
Powder and solvent for solution for injection.
| Pharmaceutical Form |
|---|
|
Powder and solvent for solution for injection. White powder and clear, colourless solvent for solution for injection. After dissolving the powder in the provided water for injections, the Haemonine solution is clear or slightly opalescent without any visible particles (see section 6.6). |
Human plasma derived coagulation factor IX;
Haemonine is presented as a powder and solvent for solution for injection containing either 500 or 1000 IU human coagulation factor IX per vial.
When reconstituted with either 5 ml or 10 ml water for injections, Haemonine contains approximately 100 IU/ml human coagulation factor IX.
The potency (IU) is determined using the European Pharmacopoeia one stage clotting test. The specific activity of Haemonine is ≥70 IU/mg protein.
Excipients with known effect: The reconstituted product contains 0.19 mmol – 0,245 mmol (4.37 mg – 5,63 mg) sodium per ml. For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Factor IX is a single chain glycoprotein with a molecular mass of about 68,000 Dalton. It is a vitamin-K dependent coagulation factor and it is synthesised in the liver. Factor IX is activated by factor XIa in the intrinsic coagulation pathway and by the factor VII/tissue factor complex in the extrinsic pathway. Activated factor IX, in combination with activated factor VIII, activates factor X. |
| List of Excipients |
|---|
|
Powder: Arginine Solvent: Water for injections. |
1 package Haemonine 500 contains:
The pack also contains: 1 disposable syringe (5 ml), 1 double-filter transfer system, 1 butterfly cannula.
1 package Haemonine 1000 contains:
The pack also contains: 1 disposable syringe (10 ml), 1 double-filter transfer system, 1 butterfly cannula.
Biotest Pharma GmbH, Landsteinerstrasse 5, 63303 Dreieich, Germany, Phone: +49 6103 801-0, Fax: +49 6103 801-150, mail@biotest.de
PL 04500/0008
19/12/2008
| Drug | Countries | |
|---|---|---|
| HAEMONINE | Austria, Tunisia, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.